FR2569M - Compositions pharmaceutiques pour le traitement local des tissus. - Google Patents

Compositions pharmaceutiques pour le traitement local des tissus.

Info

Publication number
FR2569M
FR2569M FR924505A FR924505A FR2569M FR 2569 M FR2569 M FR 2569M FR 924505 A FR924505 A FR 924505A FR 924505 A FR924505 A FR 924505A FR 2569 M FR2569 M FR 2569M
Authority
FR
France
Prior art keywords
tissues
pharmaceutical compositions
local treatment
local
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR924505A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Application granted granted Critical
Publication of FR2569M publication Critical patent/FR2569M/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR924505A 1962-02-12 1963-02-12 Compositions pharmaceutiques pour le traitement local des tissus. Active FR2569M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL274691 1962-02-12

Publications (1)

Publication Number Publication Date
FR2569M true FR2569M (fr) 1964-06-01

Family

ID=38569943

Family Applications (1)

Application Number Title Priority Date Filing Date
FR924505A Active FR2569M (fr) 1962-02-12 1963-02-12 Compositions pharmaceutiques pour le traitement local des tissus.

Country Status (2)

Country Link
ES (1) ES284759A1 (fr)
FR (1) FR2569M (fr)

Also Published As

Publication number Publication date
ES284759A1 (es) 1963-07-16

Similar Documents

Publication Publication Date Title
FR1593M (fr) Compositions pour le traitement de l'acne.
CH550853A (fr) Composition pour le traitement des textiles.
BE754628A (fr) Retracteur pour le traitement des hemorroides
FR2569M (fr) Compositions pharmaceutiques pour le traitement local des tissus.
FR3399M (fr) Produit pour le traitement de la peau.
BE598672A (fr) Composition thérapeutique pour le traitement des affections hépatiques.
FR2193M (fr) Nouveau médicament pour le traitement des maladies infectieuses.
BE630069A (fr) Composition thérapeutique pour le traitement du parkinsonisme.
FR3526M (fr) Composition thérapeutique pour le traitement de l'acné.
FR3392M (fr) Médicament dermatologique, notamment pour le traitement de l'eczéma suintant.
FR1367854A (fr) Composition pour le traitement de la chevelure
FR3277M (fr) Composition pour le traitement de dégénérescences métaboliques.
FR1329M (fr) Compositions pharmaceutiques pour le traitement de la lepre.
BE650350A (fr) Composition pour le traitement de la goutte
FR1338926A (fr) Four pour le traitement de feuillards
FR2684M (fr) Composition pharmaceutique pour le traitement local des douleurs rhumatismales.
FR2685M (fr) Composition détergente pour le traitement des affections cutanées.
FR2817M (fr) Associations de médicaments pour le traitement des désordres mentaux.
BE598665A (fr) Préparations pharmaceutiques pour le traitement de la leucémie.
FR2346M (fr) Médicament pour le traitement des colopathies.
FR1961M (fr) Compositions pour le traitement de la toxicomanie.
FR2293M (fr) Produit poue le traitement des pulpites dentaires.
FR2908M (fr) Compositions pour le traitement de l'hypercholestérolémie.
FR2786M (fr) Médicament pour le traitement des maladies cardiaques.
FR3096M (fr) Nouveau médicament notamment pour le traitement des états d'adynamie.